BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 27037874)

  • 1. Glutathione analogues as substrates or inhibitors that discriminate between allozymes of the MDR-involved human glutathione transferase P1-1.
    Zompra A; Georgakis N; Pappa E; Thireou T; Eliopoulos E; Labrou N; Cordopatis P; Clonis Y
    Biopolymers; 2016 May; 106(3):330-44. PubMed ID: 27037874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoenzyme- and allozyme-specific inhibitors: 2,2'-dihydroxybenzophenones and their carbonyl N-analogues that discriminate between human glutathione transferase A1-1 and P1-1 allozymes.
    Pouliou FM; Thireou TN; Eliopoulos EE; Tsoungas PG; Labrou NE; Clonis YD
    Chem Biol Drug Des; 2015 Nov; 86(5):1055-63. PubMed ID: 25891019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Active site architecture of polymorphic forms of human glutathione S-transferase P1-1 accounts for their enantioselectivity and disparate activity in the glutathione conjugation of 7beta,8alpha-dihydroxy-9alpha,10alpha-ox y-7,8,9,10-tetrahydrobenzo(a)pyrene.
    Hu X; O'Donnell R; Srivastava SK; Xia H; Zimniak P; Nanduri B; Bleicher RJ; Awasthi S; Awasthi YC; Ji X; Singh SV
    Biochem Biophys Res Commun; 1997 Jun; 235(2):424-8. PubMed ID: 9199210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concluding the trilogy: The interaction of 2,2'-dihydroxy-benzophenones and their carbonyl N-analogues with human glutathione transferase M1-1 face to face with the P1-1 and A1-1 isoenzymes involved in MDR.
    Georgakis ND; Karagiannopoulos DA; Thireou TN; Eliopoulos EE; Labrou NE; Tsoungas PG; Koutsilieris MN; Clonis YD
    Chem Biol Drug Des; 2017 Nov; 90(5):900-908. PubMed ID: 28440951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of differential catalytic efficiency of two polymorphic forms of human glutathione S-transferase P1-1 in the glutathione conjugation of carcinogenic diol epoxide of chrysene.
    Hu X; Ji X; Srivastava SK; Xia H; Awasthi S; Nanduri B; Awasthi YC; Zimniak P; Singh SV
    Arch Biochem Biophys; 1997 Sep; 345(1):32-8. PubMed ID: 9281308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular cloning, characterization, and expression in Escherichia coli of full-length cDNAs of three human glutathione S-transferase Pi gene variants. Evidence for differential catalytic activity of the encoded proteins.
    Ali-Osman F; Akande O; Antoun G; Mao JX; Buolamwini J
    J Biol Chem; 1997 Apr; 272(15):10004-12. PubMed ID: 9092542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Covalent Inhibitor for Glutathione S-Transferase Pi (GSTP
    Shishido Y; Tomoike F; Kuwata K; Fujikawa H; Sekido Y; Murakami-Tonami Y; Kameda T; Abe N; Kimura Y; Shuto S; Abe H
    Chembiochem; 2019 Apr; 20(7):900-905. PubMed ID: 30548113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and activity mechanism of some novel 2-substituted benzothiazoles as hGSTP1-1 enzyme inhibitors.
    Bolelli K; Musdal Y; Aki-Yalcin E; Mannervik B; Yalcin I
    SAR QSAR Environ Res; 2017 Nov; 28(11):927-940. PubMed ID: 29206502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocarbonyl Curcumin Analogues as Potent Inhibitors against Human Glutathione Transferase P1-1.
    Pantiora P; Furlan V; Matiadis D; Mavroidi B; Perperopoulou F; Papageorgiou AC; Sagnou M; Bren U; Pelecanou M; Labrou NE
    Antioxidants (Basel); 2022 Dec; 12(1):. PubMed ID: 36670925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of atrazine biotransformation by human and murine glutathione S-transferases.
    Abel EL; Opp SM; Verlinde CL; Bammler TK; Eaton DL
    Toxicol Sci; 2004 Aug; 80(2):230-8. PubMed ID: 15115887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of human glutathione S-transferase hGSTP1-1 polymorphism on the detoxification of reactive metabolites of clozapine, diclofenac and acetaminophen.
    Dragovic S; Venkataraman H; Begheijn S; Vermeulen NP; Commandeur JN
    Toxicol Lett; 2014 Jan; 224(2):272-81. PubMed ID: 24185126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential catalytic efficiency of allelic variants of human glutathione S-transferase Pi in catalyzing the glutathione conjugation of thiotepa.
    Srivastava SK; Singhal SS; Hu X; Awasthi YC; Zimniak P; Singh SV
    Arch Biochem Biophys; 1999 Jun; 366(1):89-94. PubMed ID: 10334868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential protection against benzo[a]pyrene-7,8-dihydrodiol-9,10-epoxide-induced DNA damage in HepG2 cells stably transfected with allelic variants of pi class human glutathione S-transferase.
    Hu X; Herzog C; Zimniak P; Singh SV
    Cancer Res; 1999 May; 59(10):2358-62. PubMed ID: 10344744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural requirements for the flavonoid-mediated modulation of glutathione S-transferase P1-1 and GS-X pump activity in MCF7 breast cancer cells.
    van Zanden JJ; Geraets L; Wortelboer HM; van Bladeren PJ; Rietjens IM; Cnubben NH
    Biochem Pharmacol; 2004 Apr; 67(8):1607-17. PubMed ID: 15041478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isozyme-specific glutathione-S-transferase inhibitors: design and synthesis.
    Lyttle MH; Hocker MD; Hui HC; Caldwell CG; Aaron DT; Engqvist-Goldstein A; Flatgaard JE; Bauer KE
    J Med Chem; 1994 Jan; 37(1):189-94. PubMed ID: 8289195
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand-induced glutathione transferase degradation as a therapeutic modality: Investigation of a new metal-mediated affinity cleavage strategy for human GSTP1-1.
    Alqarni MH; Muharram MM; Labrou NE
    Int J Biol Macromol; 2018 Sep; 116():84-90. PubMed ID: 29727648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescein diacetate (FDA) and its analogue as substrates for Pi-class glutathione S-transferase (GSTP1) and their biological application.
    Fujikawa Y; Nampo T; Mori M; Kikkawa M; Inoue H
    Talanta; 2018 Mar; 179():845-852. PubMed ID: 29310316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catalytic efficiencies of allelic variants of human glutathione S-transferase P1-1 toward carcinogenic anti-diol epoxides of benzo[c]phenanthrene and benzo[g]chrysene.
    Hu X; Xia H; Srivastava SK; Pal A; Awasthi YC; Zimniak P; Singh SV
    Cancer Res; 1998 Dec; 58(23):5340-3. PubMed ID: 9850062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for the binding of the anticancer compound 6-(7-nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol to human glutathione s-transferases.
    Federici L; Lo Sterzo C; Pezzola S; Di Matteo A; Scaloni F; Federici G; Caccuri AM
    Cancer Res; 2009 Oct; 69(20):8025-34. PubMed ID: 19808963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substrate specificity of rat liver glutathione S-transferase isoenzymes for a series of glutathione analogues, modified at the gamma-glutamyl moiety.
    Adang AE; Brussee J; Meyer DJ; Coles B; Ketterer B; van der Gen A; Mulder GJ
    Biochem J; 1988 Oct; 255(2):721-4. PubMed ID: 2904809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.